← Open Payments lookup

DANIEL KINSEY: Open Payments

NPI 1306880109 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,993 in 23 payments from 10 companies in 2025. Trend: 2023 $74 · 2024 $990 · 2025 $1,993

Food & beverage: $1,882Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$303
Alkermes, Inc.3$282
Otsuka Pharmaceutical Development & Commercialization, Inc.3$281
Axsome Therapeutics, Inc.3$233
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$205
Corium, LLC2$203
Teva Pharmaceuticals USA, Inc.2$183
E.R. Squibb & Sons, L.L.C.2$155
Boehringer Ingelheim Pharmaceuticals, Inc.1$94
ABBVIE INC.1$56

Products named: INGREZZA, ARISTADA, CAPLYTA, Azstarys, COBENFY, REJOYN, Auvelity, AUSTEDO XR.

Industry payments across IN — which companies pay providers there.